Steward Partners Investment Advisory’s Microbot Medical MBOT Stock Holding History

Steward Partners Investment Advisory’s Portfolio MBOT Stock Details MBOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.49K	Hold	2,300	–	–	﹤0.01%	4014
2026 Q1	$5.54K	Buy	2,300 +1,000	+77%	+$2.23K	﹤0.01%	3760
2025 Q4	$2.6K	Hold	1,300	–	–	﹤0.01%	3887
2025 Q3	$3.96K	Hold	1,300	–	–	﹤0.01%	3728
2025 Q2	$3.28K	Hold	1,300	–	–	﹤0.01%	3604
2025 Q1	$1.96K	Hold	1,300	–	–	﹤0.01%	3647
2024 Q4	$1.46K	Sell	1,300 -1,000	-43%	-$978	﹤0.01%	3702
2024 Q3	$2.06K	Hold	2,300	–	–	﹤0.01%	3432
2024 Q2	$2.35K	Hold	2,300	–	–	﹤0.01%	3249
2024 Q1	$2.83K	Hold	2,300	–	–	﹤0.01%	3217
2023 Q4	$3.77K	Sell	2,300 -2,500	-52%	-$3.33K	﹤0.01%	3069
2023 Q3	$6.67K	Hold	4,800	–	–	﹤0.01%	2728
2023 Q2	$13.1K	Sell	4,800 -1,000	-17%	-$2K	﹤0.01%	2480
2023 Q1	$12.1K	Hold	5,800	–	–	﹤0.01%	2472
2022 Q4	$17.5K	Sell	5,800 -4,800	-45%	-$19.9K	﹤0.01%	2304
2022 Q3	$51K	Sell	10,600 -1,000	-9%	-$5.14K	﹤0.01%	1774
2022 Q2	$60K	Hold	11,600	–	–	﹤0.01%	1716
2022 Q1	$73K	Hold	11,600	–	–	﹤0.01%	1729
2021 Q4	$87K	Hold	11,600	–	–	﹤0.01%	1653
2021 Q3	$82K	Hold	11,600	–	–	﹤0.01%	1641
2021 Q2	$92K	Hold	11,600	–	–	﹤0.01%	2390
2021 Q1	$98.7K	Hold	11,600	–	–	﹤0.01%	1631
2020 Q4	$80K	Sell	11,600 -6,000	-34%	-$45K	﹤0.01%	1462
2020 Q3	$134K	Buy	17,600 +2,000	+13%	+$14.1K	﹤0.01%	1101
2020 Q2	$108K	Hold	15,600	–	–	﹤0.01%	1122
2020 Q1	$86K	Buy	15,600 +12,600	+420%	+$110K	﹤0.01%	1054
2019 Q4	$30K	Hold	3,000	–	–	﹤0.01%	1622
2019 Q3	$15K	Hold	3,000	–	–	﹤0.01%	1837
2019 Q2	$15K	Buy	+3,000	New	+$19.9K	﹤0.01%	1812
2018 Q4	–	Sell	-67	Closed	-$1K	–	1572
2018 Q3	$1K	Hold	67	–	–	﹤0.01%	2504
2018 Q2	$1K	Hold	67	–	–	﹤0.01%	2359
2018 Q1	$0	Hold	67	–	–	﹤0.01%	2278
2017 Q4	$1K	Buy	+67	New	+$1.14K	﹤0.01%	1793

Other funds holding MBOT

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Steward Partners Investment Advisory's MBOT Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Microbot Medical (MBOT) position steady in Q2 2026 at 2,300 shares worth $4.49K. The position accounts for ﹤0.01% of the portfolio, ranked #4014.

Steward Partners Investment Advisory first reported a position in MBOT in Q4 2017 and has held it in 33 quarters since. The position peaked at $134K in Q3 2020. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

Steward Partners Investment Advisory held 2,300 shares of Microbot Medical worth $4.49K as of Q2 2026.
Steward Partners Investment Advisory left its Microbot Medical share count unchanged in Q2 2026.
Microbot Medical made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4014 holding.
Steward Partners Investment Advisory first reported a position in Microbot Medical in Q4 2017 and has held it in 33 quarters since.
Steward Partners Investment Advisory's Microbot Medical position peaked at $134K in Q3 2020.
71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.